The Patent Finder

Intradigm Corporation

Also on record
Records under this name other than patents Intradigm Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Intradigm Corporation

PatentTitleStatus Expires Confidence
US 8,691,781Compositions for treating respiratory viral infections and their use
Term ended
Term ended Nov 1, 2025 · From the USPTO record
Term endedTerm ended Nov 1, 2025From the USPTO record
US 7,893,243Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
Lapsed on the fee record
Ended Feb 22, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 22, 2015From the USPTO record
US 7,893,244Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
Lapsed on the fee record
Ended Feb 22, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 22, 2015From the USPTO record
US 7,786,092Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases
Lapsed on the fee record
Ended Aug 31, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 31, 2014From the USPTO record
US 7,781,414Targets for tumor growth inhibition
Lapsed on the fee record
Ended Aug 24, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 24, 2014From the USPTO record
US 7,723,316Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
Lapsed on the fee record
Ended May 25, 2014 · From the USPTO record
Lapsed on the fee recordEnded May 25, 2014From the USPTO record
US 7,534,878Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
Lapsed on the fee record
Ended May 19, 2013 · From the USPTO record
Lapsed on the fee recordEnded May 19, 2013From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited